{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T02:17:31Z","timestamp":1789352251865,"version":"build-2803163510"},"reference-count":11,"publisher":"Centers for Disease Control and Prevention (CDC)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Emerg. Infect. Dis."],"DOI":"10.3201\/eid1408.071059","type":"journal-article","created":{"date-parts":[[2008,9,26]],"date-time":"2008-09-26T13:28:51Z","timestamp":1222435731000},"page":"1259-1262","source":"Crossref","is-referenced-by-count":39,"title":["Increased Amoxicillin\u2013Clavulanic Acid Resistance in\n                    <i>Escherichia coli<\/i>\n                    Blood Isolates, Spain"],"prefix":"10.3201","volume":"14","author":[{"given":"Jes\u00fas","family":"Oteo","sequence":"first","affiliation":[{"name":"Instituto de Salud Carlos III, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Campos","sequence":"additional","affiliation":[{"name":"Instituto de Salud Carlos III, Madrid, SpainConsejo Superior de Investigaciones Cient\u00edficas, Madrid"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edurne","family":"L\u00e1zaro","sequence":"additional","affiliation":[{"name":"Agencia Espa\u00f1ola del Medicamento y Productos Sanitarios, Madrid"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d3scar","family":"Cuevas","sequence":"additional","affiliation":[{"name":"Instituto de Salud Carlos III, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Garc\u00eda-Cobos","sequence":"additional","affiliation":[{"name":"Instituto de Salud Carlos III, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"P\u00e9rez-V\u00e1zquez","sequence":"additional","affiliation":[{"name":"Instituto de Salud Carlos III, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. J.","family":"de Abajo","sequence":"additional","affiliation":[{"name":"Agencia Espa\u00f1ola del Medicamento y Productos Sanitarios, Madrid"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Spanish Members of EARSS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1822","published-online":{"date-parts":[[2008,8]]},"reference":[{"key":"key-10.3201\/eid1408.071059-201210031105-R1","doi-asserted-by":"publisher","first-page":"546","DOI":"10.3201\/eid1104.040699","article-title":"Spanish members of EARSS. Antimicrobial-resistant invasive Escherichia coli, Spain.","volume":"11","author":"Oteo","year":"2005","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid1408.071059-201210031105-R2","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1086\/313710","article-title":"Antimicrobial susceptibility and frequency of occurrence of clinical blood isolates in Europe from the SENTRY antimicrobial surveillance program, 1997\u20131998.","volume":"30","author":"Fluit","year":"2000","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid1408.071059-201210031105-R3","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S0732-8893(01)00284-X","article-title":"Four-year prospective evaluation of community-acquired bacteremia: epidemiology, microbiology and patient outcome.","volume":"41","author":"Lark","year":"2001","journal-title":"Diagn Microbiol Infect Dis"},{"key":"key-10.3201\/eid1408.071059-201210031105-R4","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0140-6736(05)17907-0","article-title":"Outpatient antibiotic use in Europe and association with resistance: a cross-national database study.","volume":"365","author":"Goossens","year":"2005","journal-title":"Lancet"},{"key":"key-10.3201\/eid1408.071059-201210031105-R5","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0025-7753(02)72453-6","article-title":"Evoluci\u00f3n del consumo de antibi\u00f3ticos en Espa\u00f1a, 1985\u20132000.","volume":"118","author":"L\u00e1zaro","year":"2002","journal-title":"Med Clin (Barc)"},{"key":"key-10.3201\/eid1408.071059-201210031105-R6","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1093\/jac\/dkm248","article-title":"Surveillance of outpatient antibiotic consumption in Spain according to sales data and reimbursement data.","volume":"60","author":"Campos","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"key-10.3201\/eid1408.071059-201210031105-R7","unstructured":"European Antimicrobial Resistance Surveillance System [cited 2007 Jan 8]. Available from http:\/\/www.rivm.nl\/earss"},{"key":"key-10.3201\/eid1408.071059-201210031105-R8","unstructured":"Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing\u201417th informational supplement. M100\u2013S17. Vol 27, No. 1. Wayne (PA): The Institute; 2007 [cited 2008 Jun 27]. Available from http:\/\/www.clsi.org"},{"key":"key-10.3201\/eid1408.071059-201210031105-R9","unstructured":"World Health Organization Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC classification and DDD assignment. Oslo (Norway): The Organization; 2005."},{"key":"key-10.3201\/eid1408.071059-201210031105-R10","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1093\/jac\/49.2.367","article-title":"Exposure to co-amoxiclav as a risk factor for co-amoxiclav-resistant Escherichia coli urinary tract infection.","volume":"49","author":"Leflon-Guibout","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"key-10.3201\/eid1408.071059-201210031105-R11","doi-asserted-by":"publisher","first-page":"3991","DOI":"10.1128\/AAC.46.12.3991-3994.2002","article-title":"Prevalence of clinical isolates of Escherichia coli producing inhibitor-resistant period.","volume":"46","author":"Mir\u00f3","year":"2002","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Emerging Infectious Diseases"],"original-title":[],"link":[{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/14\/8\/07-1059_article","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T09:29:04Z","timestamp":1732613344000},"score":1,"resource":{"primary":{"URL":"http:\/\/wwwnc.cdc.gov\/eid\/article\/14\/8\/07-1059_article.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8]]},"references-count":11,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2008,8]]}},"URL":"https:\/\/doi.org\/10.3201\/eid1408.071059","relation":{},"ISSN":["1080-6040","1080-6059"],"issn-type":[{"value":"1080-6040","type":"print"},{"value":"1080-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,8]]}}}